跳至主要内容
临床试验/IRCT20191221045837N1
IRCT20191221045837N1尚未招募2 期

Evaluation of the Efficacy of Nanomicelle Curcumin Formulation in Children with Juvenile Idiopathic Arthritis(JIA)

Mashhad University of Medical Sciences0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
尚未招募
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
6 years 至 16 years(—)
性别
All

入选标准

  • All children between 6 and 16 years old referring to Akbar hospital Rheumatology subspecialty clinic who diagnosed suffering JIA according to ACR Guidline1
  • Obtain patient/patient's parents informed consent

排除标准

  • Children under 6 years old and or teenagers older than 16 years old
  • Child with a history of underlying diseases including heart, kidney, liver, bile, digestive and or reumatoid ( any kind of reumatoid diseases except JIA) diseases simultaneous
  • Consuming anticoagulant medicines like warfarin or anti-platelet medicines by patient
  • Diabetic patients

研究者

相似试验